What Is Peptide Therapy?
Peptide therapy covers a broad spectrum — from FDA-approved GLP-1 drugs prescribed by physicians to investigational compounds studied in research settings. This guide explains what it is, how it works, and how clinical therapy differs from research use.
Source Research Peptides at Purgo Labs
Third-party tested, ≥99% purity, COA with every batch.
Research Purposes Only. This guide is for educational and scientific reference. Research peptides discussed on this site are sold strictly for laboratory use and are not intended for human therapeutic use. Always consult a qualified healthcare professional before using any peptide compound or pursuing peptide therapy.
Defining Peptide Therapy
Peptide therapy is the clinical or research application of peptide compounds to modulate specific biological pathways. Peptides are short chains of amino acids (typically 2–50 residues) that function as signaling molecules in the body — binding to receptors and triggering precise cellular responses. Unlike small-molecule drugs, peptides interact with receptors at a structural level that closely mimics natural biological signals.
The term "peptide therapy" is used across a wide spectrum: from rigorously studied FDA-approved drugs (semaglutide, tirzepatide) prescribed by physicians for specific indications, to investigational compounds used in anti-aging clinics under physician supervision, to research-grade compounds studied in laboratory settings outside of a clinical context.
Understanding where a specific peptide falls on this spectrum — and what evidence supports its use — is essential for evaluating any peptide therapy claim.
Peptide Therapy vs. Research Use
These two contexts are often conflated but are legally and medically distinct.
| Aspect | Clinical Peptide Therapy | Research Use |
|---|---|---|
| Administration | Prescribed and supervised by a licensed physician or clinic | Self-administered by researcher; no medical supervision required |
| Compounds used | FDA-approved drugs or legally compounded preparations | Research-grade compounds from licensed suppliers |
| Legal framework | Regulated as medical treatment under FDA drug law | Legal for laboratory research; not for human therapeutic use |
| Quality standards | Pharmaceutical GMP manufacturing; ≥99.5% purity | Research-grade; ≥99% HPLC purity from reputable suppliers |
| Monitoring | Regular biomarker testing, physician follow-up | Researcher's discretion; no standardized protocol |
| Evidence base | Requires FDA approval or off-label use of approved drugs | Preclinical and Phase I/II data; human safety not established |
| Cost | Insurance may cover FDA-approved indications; out-of-pocket for off-label | Generally lower cost; no insurance coverage |
Peptide Therapy by Category
Metabolic & Weight Management
The fastest-growing area of peptide therapy, driven by the success of GLP-1 receptor agonists.
Peptides: Semaglutide, Liraglutide, Tirzepatide
Evidence: Phase III RCTs (SUSTAIN, STEP, SURMOUNT trials)
Reduces appetite, slows gastric emptying, and improves glycemic control. 15–22% body weight reduction in clinical trials.
Peptides: Tesamorelin (Egrifta)
Evidence: Phase III RCTs in HIV+ patients
Reduces visceral adipose tissue in HIV-associated lipodystrophy. Only FDA-approved indication for a GHRH analogue.
Peptides: CJC-1295, Ipamorelin, Sermorelin
Evidence: Phase I/II data; compounding now restricted
Stimulates endogenous GH release for body composition and metabolic effects. Widely used in anti-aging clinics prior to 2023 FDA compounding restrictions.
Tissue Repair & Recovery
Peptides studied for accelerating healing of musculoskeletal injuries, gut lining, and wound repair.
Peptides: BPC-157 (Body Protection Compound)
Evidence: Preclinical (animal models); no human RCTs
Studied for tendon/ligament repair, gut healing, and neuroprotection in rodent models. Widely used in research settings despite lack of human clinical trial data.
Peptides: Thymosin Beta-4
Evidence: Phase II wound healing trials; no approved indication
Promotes actin polymerization and cell migration. Studied for wound healing, cardiac repair, and CNS injury in preclinical and early clinical research.
Peptides: Thymalfasin (Zadaxin)
Evidence: RCTs in hepatitis B/C, cancer immunotherapy
Immune modulator used in Asia and Europe for hepatitis, cancer, and immunodeficiency. Not FDA-approved in the US.
Anti-Aging & Longevity
Peptide interventions targeting the biological mechanisms of aging — telomere length, immune senescence, and GH decline.
Peptides: Epithalon (Epitalon)
Evidence: Russian longevity studies; limited Western RCT data
Tetrapeptide that activates telomerase and may extend telomere length. Studied in Russian longevity research for 30+ years. Limited peer-reviewed data in Western literature.
Peptides: GHK-Cu (copper peptide)
Evidence: In vitro and animal studies; limited human RCTs
Stimulates collagen synthesis, wound healing, and has antioxidant properties. Widely used in topical skincare; systemic research use is investigational.
Peptides: Recombinant hGH (Somatropin)
Evidence: Extensive RCT data
FDA-approved for GH deficiency in children and adults, Turner syndrome, and HIV wasting. Off-label use for anti-aging is not FDA-approved.
Sexual Health
Melanocortin-based peptide therapies targeting sexual dysfunction.
Peptides: Bremelanotide (Vyleesi)
Evidence: Phase III RCTs (RECONNECT trials)
FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women. Melanocortin receptor agonist administered subcutaneously before sexual activity.
Peptides: PT-141 (Bremelanotide analogue)
Evidence: Phase II data; compounding status uncertain
Melanocortin agonist studied for both male and female sexual dysfunction. Related to bremelanotide but not FDA-approved in compounded form.
Cognitive & Neurological
Peptide interventions targeting neuroplasticity, anxiety, and cognitive function.
Peptides: Selank
Evidence: Russian clinical trials for anxiety
Anxiolytic peptide derived from tuftsin. Approved in Russia for anxiety and cognitive enhancement. Research use only in the US.
Peptides: Dihexa
Evidence: Preclinical (rodent models)
Angiotensin IV analogue that promotes synaptogenesis. Studied for cognitive enhancement and neurodegeneration in preclinical models. No human clinical trials.
Peptides: Semax
Evidence: Russian clinical trials for stroke, ADHD
ACTH analogue with nootropic and neuroprotective properties. Approved in Russia for ischemic stroke and cognitive impairment. Research use only in the US.
Why Peptides Are Useful as Therapeutic Agents
Receptor Specificity
Peptides are designed to bind specific receptors with high affinity. This precision reduces off-target effects compared to many small-molecule drugs, which often interact with multiple receptor families.
Mimics Natural Signals
Many therapeutic peptides are analogues of endogenous peptides (GLP-1, GHRH, oxytocin). They activate the same receptors as the body's own signaling molecules, producing physiologically familiar responses.
Short Half-Life (controllable)
Most peptides are rapidly degraded by proteases. This is a therapeutic advantage — effects are time-limited and dose-controllable. Modified analogues (like semaglutide) extend half-life through fatty acid conjugation.
Low Immunogenicity
Peptides derived from or closely resembling endogenous sequences have low immunogenic potential compared to larger protein biologics, reducing the risk of antibody-mediated neutralization.
Diverse Mechanisms
Peptides can act as receptor agonists, antagonists, enzyme inhibitors, or structural modulators. This versatility makes them applicable across metabolic, neurological, immunological, and regenerative medicine.
Emerging Manufacturing
Solid-phase peptide synthesis (SPPS) and recombinant production methods have made peptide manufacturing increasingly cost-effective, enabling commercial development of compounds that were previously too expensive to produce at scale.
Related Research Guides
Frequently Asked Questions
What is peptide therapy?
Peptide therapy refers to the clinical use of peptide compounds — either FDA-approved peptide drugs or legally compounded peptide preparations — administered under medical supervision to treat specific health conditions or optimize physiological function. It encompasses a wide range of applications including metabolic regulation (GLP-1 agonists for weight loss), tissue repair, anti-aging, sexual health, and cognitive enhancement. Peptide therapy is distinct from self-administered research use of non-approved compounds.
How does peptide therapy work?
Peptides function as signaling molecules that bind to specific receptors and trigger targeted cellular responses. In therapeutic applications, this precision is a key advantage — a GLP-1 receptor agonist specifically activates GLP-1 receptors to regulate appetite and blood sugar, while a GHRH analogue specifically stimulates growth hormone release. The mechanism depends entirely on the peptide and its target receptor.
Is peptide therapy the same as using research peptides?
No. Peptide therapy in a clinical context refers to medically supervised use of FDA-approved drugs or legally compounded preparations. Research peptides are compounds sold for laboratory use that are not approved for human administration. The distinction matters legally, medically, and in terms of evidence quality — FDA-approved peptide therapies have extensive clinical trial data; research peptides typically do not.
What conditions is peptide therapy used for?
FDA-approved peptide therapies are used for type 2 diabetes and obesity (GLP-1 agonists), HIV-associated lipodystrophy (tesamorelin), hypoactive sexual desire disorder (bremelanotide), and growth hormone deficiency (somatropin). Research and investigational peptide therapies are being studied for tissue repair, anti-aging, cognitive enhancement, immune modulation, and neurological conditions.
How do I find a peptide therapy clinic?
Peptide therapy clinics typically operate as functional medicine, anti-aging, or integrative health practices. When evaluating a clinic, look for licensed physicians (MD or DO), transparent disclosure of which compounds are FDA-approved vs. compounded, third-party testing of compounded preparations, and biomarker monitoring protocols. Be cautious of clinics that prescribe compounds restricted by the 2023 FDA compounding guidance (BPC-157, TB-500, sermorelin, CJC-1295) — these are no longer legally compoundable for human use.
What is the difference between peptide therapy and hormone replacement therapy (HRT)?
Hormone replacement therapy (HRT) involves administering exogenous hormones (estrogen, testosterone, progesterone) to replace declining endogenous levels. Peptide therapy, particularly with GH secretagogues, works differently — rather than replacing a hormone directly, it stimulates the body's own endocrine system to produce more of it. This distinction has implications for the feedback loop: peptide-stimulated GH release maintains pulsatility and negative feedback, whereas exogenous GH administration does not.